5-Amino-1MQ: Keep the Mouse Label Visible
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

5-Amino-1MQ is a small-molecule research inhibitor of NNMT, an enzyme involved in nicotinamide metabolism. It is not a peptide, despite frequent grouping with peptides. Researchers studied related compounds in laboratory assays and fat cells, then tested 5-Amino-1MQ in mice with obesity induced by a high-fat diet. The short mouse experiment reported lower body weight and fat mass without a measured reduction in food intake. These findings support further investigation. They do not establish effective weight management in people. Human exposure, patient-important outcomes and longer-term safety require direct testing of the exact compound.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Neelakantan et al. (2018): Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
https://pmc.ncbi.nlm.nih.gov/articles/PMC5826726/
Primary laboratory, adipocyte and diet-induced obese mouse study

EVIDENCE LIMITATIONS
The main in vivo experiment was an eleven-day mouse study, not a patient trial.
A measured lack of food-intake reduction does not establish the complete mechanism.
Absence of observed short-term adverse effects cannot establish human or long-term safety.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
5-Amino-1MQ: Mouse Metabolism Is Not Human Treatment Evidence